In contrast, at pH 8.4, 8-Br-cGMP increased I-TASK1 evoked at 0, +30, and +60 mV barely significantly ( p = 0.049, two-way ANOVA: pH effect, F(1, 4) = 7.84) and only by 16%, 14%, and 11%, respectively ( Figure 3 (B1,B2); 0 mV, p = 0.002; +30 mV, p < 0.001; +60 mV, p < 0.001, two-way ANOVA followed by Fisher’s PLSD; n = 5).
There was no main effect of gender, F 1,186 = 0.88, p = 0.350, but there was a marginally significant group by gender interaction, F 1,186 = 3.92, p = 0.049.
However, no effect of baseline on the GCA mean (i.e., on the average dilation, analogous to the MPD) was found, and a small and only marginally significant (p = 0.049) positive effect was found of the baseline on the PPD.
Results The good cognitive recovery group had an interesting trend of higher IL-13 than the poor cognitive recovery group (good cognitive recovery group 257.82 ± 268.76 vs. poor cognitive recovery group 191.67 ± 201.82, p = 0.049, unit: pg/ml).
JA in infected Col-0 at 8 h was lower than in C24 at 8 h, reflecting the delay in the response in Col-0, although the difference was only marginally significant ( t -test, p = 0.049).
By comparison, the relationship between spiral index and CCI was weaker in the coarse version of the task, which was reflected by a marginal significance ( p = 0.049, Spearman rank correlation) in monkey R, and non-significance ( p = 0.89, Spearman rank correlation) in monkey A.
Difference in seizure reduction between CBD and placebo emerged on Day 6 (titrated dose, 15 mg/kg/day) and became nominally significant ( p < .049) by Day 10.
After adjusting for age, previous AKI, HTN, and pre-AKI kidney function, the odds ratio remained marginally significant at 1.02 (95% CI: 1.0–1.5), p = 0.049.
This generalized linear mixed model revealed a significant main effect of fairness ( F (1, 3217) = 4.77, p = 0.029) and a marginally significant group by fairness interaction effect ( F (1, 3217) = 3.87, p = 0.049).
Another study of intrahepatic CCA with 53 patients found that CD3+ lymphocytes had a borderline significance (P=0.049) for independent positive impact on OS while FOXP3+ lymphocytes presented possible independent negative impact (P=0.044) ( 23 ).
A subsequent memory contrast within this cluster indicated greater positivity for mismatched targets that were subsequently remembered (hits) relative to mismatched targets that were subsequently forgotten (misses) in the attentive group, although this effect was only weakly significant in a t -test [ t (12) = 2.185, P = 0.049, two-tailed; Fig. 3E] and a Bayesian equivalent indicated that the evidence was only anecdotal (BF10 = 1.628).
Analysis of rs12997 in PXG patients showed a trend towards association as compared to controls (Table 4 ) with G/G genotype resulting in a 2-fold increased of disease ( p = 0.049) in co-dominant model.
Fibrinogen γ demonstrated a borderline significant difference in the overall ANOVA analysis (P=0.049), while subsequent post hoc multiple comparisons did not identify any statistically significant differences between the groups (KDSS vs.
Interestingly, the model indicated that the stimulation threshold would be lower in patients with recurrent metastasis with marginal significance ( p = 0.049).
The difference between CON + SAL and KA + MI was only marginally significant (T = 2.23, p = 0.049, DF = 10), whereas the difference between the KA + MI and KA + SAL groups was not significant on 2-tailed test (T = 2.19, p = 0.053, DF = 10).
4 In the landmark paper from Woodle et al , 4 the incidence of diabetes was similar with a 5-year follow-up comparing low dose maintenance versus withdrawal at day 7 after transplantation, while insulin requirement was barely significantly increased in the maintenance group (3.7% vs. 11.6%, P = 0.049). 2 , 3 , 4 In the current issue of KI Reports , Ekberg et al. 5 report on a randomized controlled trial on safety of steroid avoidance in low-immunologic risk kidney transplant recipients.
For the participants with past history of COVID-19, there was a nominally significant increase in GMT at 21-days after second dose (p = 0.049) compared to 21-days after first dose (baseline value), and no significant difference noted compared to baseline value at 3-months (p = 0.26) and 6-months (p = 0.15) after the second dose.
The fit of the owner’s characterstics model demonstrated a trend towards significance ( p = 0.049 ) and explained only 7% of the variance, while the pet–human relationship explained only 5% of the variance ( Table 2 ).
More patients with dysphagia (44.44%, 8/18) had a history of alcohol drinking than those without dysphagia (16.67%, 4/24), and it showed a marginally significant difference ( P = 0.049). 4.
Exercise significantly elevated BDNF IV levels in comparison to ETP69 treatment, but failed to reach significance relative to sedentary controls ( Figure 2E ; Welch’s ANOVA, * p = 0.049; Dunnett’s post hoc test, * p = 0.056 ex vs. etp).